AT2 receptors: Functional relevance in cardiovascular disease

被引:203
作者
Jones, Emma S. [1 ]
Vinh, Antony [1 ]
McCarthy, Claudia A. [1 ]
Gaspari, Tracey A. [1 ]
Widdop, Robert E. [1 ]
机构
[1] Monash Univ, Dept Pharmacol, Clayton, Vic 3800, Australia
基金
英国医学研究理事会;
关键词
Angiotensin II; AT(2) receptor; AT(1) receptor; Cardiovascular disease;
D O I
10.1016/j.pharmthera.2008.08.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The renin angiotensin system (RAS) is intricately involved in normal cardiovascular homeostasis. Excessive stimulation by the octapeptide angiotensin II contributes to a range of cardiovascular pathologies and diseases via angiotensin type 1 receptor (AT(1)R) activation. On the other hand, tElsevier Inc.he angiotensin type 2 receptor (AT(2)R) is thought to counter-regulate AT, R function. In this review, we describe the enhanced expression and function of AT(2)R in various cardiovascular disease settings. In addition, we illustrate that the RAS consists of a family of angiotensin peptides that exert cardiovascular effects that are often distinct from those of Ang II. During cardiovascular disease, there is likely to be an increased functional importance of AT(2)R stimulated by Ang II, or even shorter angiotensin pepticle fragments, to limit AT(1)R-mediated overactivity and cardiovascular pathologies. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:292 / 316
页数:25
相关论文
共 446 条
  • [41] BRECHLER V, 1994, RECEPTOR CHANNEL, V2, P89
  • [42] Cardiac hypertrophy is associated with decreased eNOS expression in angiotensin AT2 receptor-deficient mice
    Brede, M
    Roell, W
    Ritter, O
    Wiesmann, F
    Jahns, R
    Haase, A
    Fleischmann, BK
    Hein, L
    [J]. HYPERTENSION, 2003, 42 (06) : 1177 - 1182
  • [43] Vascular hypertrophy and increased P70S6 kinase in mice lacking the angiotensin II AT2 receptor
    Brede, M
    Hadamek, K
    Meinel, L
    Wiesmann, F
    Peters, J
    Engelhardt, S
    Simm, A
    Haase, A
    Lohse, MJ
    Hein, L
    [J]. CIRCULATION, 2001, 104 (21) : 2602 - 2607
  • [44] Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
    Brenner, BM
    Cooper, ME
    de Zeeuw, D
    Keane, WF
    Mitch, WE
    Parving, HH
    Remuzzi, G
    Snapinn, SM
    Zhang, ZX
    Shahinfar, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) : 861 - 869
  • [45] ROLE OF ANGIOTENSIN-II AND PROSTAGLANDIN E(2) IN REGULATING CARDIAC FIBROBLAST COLLAGEN TURNOVER
    BRILLA, CG
    ZHOU, GP
    RUPP, H
    MAISCH, B
    WEBER, KT
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1995, 76 (13) : D8 - D13
  • [46] COLLAGEN-METABOLISM IN CULTURED ADULT-RAT CARDIAC FIBROBLASTS - RESPONSE TO ANGIOTENSIN-II AND ALDOSTERONE
    BRILLA, CG
    ZHOU, GP
    MATSUBARA, L
    WEBER, KT
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1994, 26 (07) : 809 - 820
  • [47] Effects of intravenous PD 123319 on haemodynamic and arterial stiffness indices in healthy volunteers
    Brillante, DG
    Johnstone, MT
    Howes, LG
    [J]. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2005, 6 (02) : 102 - 106
  • [48] Arterial stiffness and haemodynamic response to vasoactive medication in subjects with insulin-resistance syndrome
    Brillante, Divina G.
    O'Sullivan, Anthony J.
    Johnstone, Martina T.
    Howes, Laurence G.
    [J]. CLINICAL SCIENCE, 2008, 114 (1-2) : 139 - 147
  • [49] Localization of the angiotensin II receptor subtypes in the human atrium
    Brink, M
    Erne, P
    deGasparo, M
    Rogg, H
    Schmid, A
    Stulz, P
    Bullock, G
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1996, 28 (08) : 1789 - 1799
  • [50] Tissue-specific changes in angiotensin II receptors in streptozotocin-diabetic rats
    Brown, L
    Wall, D
    Marchant, C
    Sernia, C
    [J]. JOURNAL OF ENDOCRINOLOGY, 1997, 154 (02) : 355 - 362